THNR ETF
THNR ETF
$25.69
Amplify Weight Loss Drug & Treatment ETF
AUM$5M
TER0.59%
Holdings22
See how much of THNR you already own
NVO:OS is THNR's largest holding at 8.89% of the fund as of Sep 1, 2026. THNR is Amplify Weight Loss Drug & Treatment ETF.
THNR ETF All Holdings
THNR holdings total 22 positions. The top 10 holdings account for 62.5% of the fund, led by Novo-Nordisk A/S-Spons Adr at 8.9%, Eli Lilly & Co. at 8.6%, Innovent Biologics Inc at 6.3%.
THNR portfolio concentration is relatively high, with the top 10 representing 62.5% of total assets. The largest sector exposure is Health Care at 80.5%.
THNR sectors provide a detailed breakdown. THNR overlap shows how holdings compare to other funds in your portfolio.













